MRM — MEDIROM Healthcare Technologies Income Statement
0.000.00%
Last trade - 00:00
Consumer DefensivesAdventurousMicro Cap
- $19.14m
- $21.63m
- ¥3bn
2018 December 31st | 2019 December 31st | 2020 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 20-F |
Standards: | USG | USG | USG |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 3,433 | 3,908 | 3,342 |
Cost of Revenue | |||
Gross Profit | 957 | 951 | 429 |
Selling / General / Administrative Expenses | |||
Unusual Expense / Income | |||
Total Operating Expenses | 3,360 | 3,874 | 3,976 |
Operating Profit | 73.3 | 34.4 | -635 |
Total Net Non Operating Interest Income / Expense | |||
Other Net Non Operating Costs | |||
Net Income Before Taxes | 91.9 | 32.7 | -627 |
Provision for Income Taxes | |||
Net Income After Taxes | 66.7 | 16.8 | -539 |
Net Income Before Extraordinary Items | |||
Net Income | 66.7 | 16.8 | -539 |
Adjustments to Net Income | |||
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | 66.3 | 17.3 | -539 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | 19.9 | 8.33 | -135 |